The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Rare Biomarkers Specimen Collection And Stabilization Market Research Report 2024

Global Rare Biomarkers Specimen Collection And Stabilization Market Research Report 2024

Publishing Date : Feb, 2024

License Type :
 

Report Code : 1902904

No of Pages : 78

Ask Your Query

Synopsis

Rare biomarkers in disease management has driven investments toward clinical applications.

The global Rare Biomarkers Specimen Collection And Stabilization market was valued at US$ 29000 million in 2023 and is anticipated to reach US$ 50330 million by 2030, witnessing a CAGR of 8.1% during the forecast period 2024-2030.

North American market for Rare Biomarkers Specimen Collection And Stabilization is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Rare Biomarkers Specimen Collection And Stabilization is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Rare Biomarkers Specimen Collection And Stabilization in Research is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Rare Biomarkers Specimen Collection And Stabilization include Miltenyi Biotec, QIAGEN, Creatv MicroTech, Veridex, Creative-Bioarray, Genetix, STRECK, INC., Roche and Amgen, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Rare Biomarkers Specimen Collection And Stabilization, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rare Biomarkers Specimen Collection And Stabilization.

Report Scope

The Rare Biomarkers Specimen Collection And Stabilization market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Rare Biomarkers Specimen Collection And Stabilization market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Rare Biomarkers Specimen Collection And Stabilization companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • Miltenyi Biotec
  • QIAGEN
  • Creatv MicroTech
  • Veridex
  • Creative-Bioarray
  • Genetix
  • STRECK, INC.
  • Roche
  • Amgen

Segment by Type

  • Circulating Cell Free DNA (ccfDNA)
  • Circulating Tumor Cells (CTCs)
  • Exosomes/Extracellular Vesicles
  • Circulating Cell Free RNA (ccfRNA) / miRNA

Segment by Application

  • Research
  • Diagnostics

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Rare Biomarkers Specimen Collection And Stabilization companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rare Biomarkers Specimen Collection And Stabilization Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Circulating Cell Free DNA (ccfDNA)
1.2.3 Circulating Tumor Cells (CTCs)
1.2.4 Exosomes/Extracellular Vesicles
1.2.5 Circulating Cell Free RNA (ccfRNA) / miRNA
1.3 Market by Application
1.3.1 Global Rare Biomarkers Specimen Collection And Stabilization Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Research
1.3.3 Diagnostics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Rare Biomarkers Specimen Collection And Stabilization Market Perspective (2019-2030)
2.2 Rare Biomarkers Specimen Collection And Stabilization Growth Trends by Region
2.2.1 Global Rare Biomarkers Specimen Collection And Stabilization Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Rare Biomarkers Specimen Collection And Stabilization Historic Market Size by Region (2019-2024)
2.2.3 Rare Biomarkers Specimen Collection And Stabilization Forecasted Market Size by Region (2025-2030)
2.3 Rare Biomarkers Specimen Collection And Stabilization Market Dynamics
2.3.1 Rare Biomarkers Specimen Collection And Stabilization Industry Trends
2.3.2 Rare Biomarkers Specimen Collection And Stabilization Market Drivers
2.3.3 Rare Biomarkers Specimen Collection And Stabilization Market Challenges
2.3.4 Rare Biomarkers Specimen Collection And Stabilization Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Rare Biomarkers Specimen Collection And Stabilization Players by Revenue
3.1.1 Global Top Rare Biomarkers Specimen Collection And Stabilization Players by Revenue (2019-2024)
3.1.2 Global Rare Biomarkers Specimen Collection And Stabilization Revenue Market Share by Players (2019-2024)
3.2 Global Rare Biomarkers Specimen Collection And Stabilization Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Rare Biomarkers Specimen Collection And Stabilization Revenue
3.4 Global Rare Biomarkers Specimen Collection And Stabilization Market Concentration Ratio
3.4.1 Global Rare Biomarkers Specimen Collection And Stabilization Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rare Biomarkers Specimen Collection And Stabilization Revenue in 2023
3.5 Rare Biomarkers Specimen Collection And Stabilization Key Players Head office and Area Served
3.6 Key Players Rare Biomarkers Specimen Collection And Stabilization Product Solution and Service
3.7 Date of Enter into Rare Biomarkers Specimen Collection And Stabilization Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Rare Biomarkers Specimen Collection And Stabilization Breakdown Data by Type
4.1 Global Rare Biomarkers Specimen Collection And Stabilization Historic Market Size by Type (2019-2024)
4.2 Global Rare Biomarkers Specimen Collection And Stabilization Forecasted Market Size by Type (2025-2030)
5 Rare Biomarkers Specimen Collection And Stabilization Breakdown Data by Application
5.1 Global Rare Biomarkers Specimen Collection And Stabilization Historic Market Size by Application (2019-2024)
5.2 Global Rare Biomarkers Specimen Collection And Stabilization Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Rare Biomarkers Specimen Collection And Stabilization Market Size (2019-2030)
6.2 North America Rare Biomarkers Specimen Collection And Stabilization Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Rare Biomarkers Specimen Collection And Stabilization Market Size by Country (2019-2024)
6.4 North America Rare Biomarkers Specimen Collection And Stabilization Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Rare Biomarkers Specimen Collection And Stabilization Market Size (2019-2030)
7.2 Europe Rare Biomarkers Specimen Collection And Stabilization Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Rare Biomarkers Specimen Collection And Stabilization Market Size by Country (2019-2024)
7.4 Europe Rare Biomarkers Specimen Collection And Stabilization Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Rare Biomarkers Specimen Collection And Stabilization Market Size (2019-2030)
8.2 Asia-Pacific Rare Biomarkers Specimen Collection And Stabilization Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Rare Biomarkers Specimen Collection And Stabilization Market Size by Region (2019-2024)
8.4 Asia-Pacific Rare Biomarkers Specimen Collection And Stabilization Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Rare Biomarkers Specimen Collection And Stabilization Market Size (2019-2030)
9.2 Latin America Rare Biomarkers Specimen Collection And Stabilization Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Rare Biomarkers Specimen Collection And Stabilization Market Size by Country (2019-2024)
9.4 Latin America Rare Biomarkers Specimen Collection And Stabilization Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Rare Biomarkers Specimen Collection And Stabilization Market Size (2019-2030)
10.2 Middle East & Africa Rare Biomarkers Specimen Collection And Stabilization Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Rare Biomarkers Specimen Collection And Stabilization Market Size by Country (2019-2024)
10.4 Middle East & Africa Rare Biomarkers Specimen Collection And Stabilization Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Miltenyi Biotec
11.1.1 Miltenyi Biotec Company Detail
11.1.2 Miltenyi Biotec Business Overview
11.1.3 Miltenyi Biotec Rare Biomarkers Specimen Collection And Stabilization Introduction
11.1.4 Miltenyi Biotec Revenue in Rare Biomarkers Specimen Collection And Stabilization Business (2019-2024)
11.1.5 Miltenyi Biotec Recent Development
11.2 QIAGEN
11.2.1 QIAGEN Company Detail
11.2.2 QIAGEN Business Overview
11.2.3 QIAGEN Rare Biomarkers Specimen Collection And Stabilization Introduction
11.2.4 QIAGEN Revenue in Rare Biomarkers Specimen Collection And Stabilization Business (2019-2024)
11.2.5 QIAGEN Recent Development
11.3 Creatv MicroTech
11.3.1 Creatv MicroTech Company Detail
11.3.2 Creatv MicroTech Business Overview
11.3.3 Creatv MicroTech Rare Biomarkers Specimen Collection And Stabilization Introduction
11.3.4 Creatv MicroTech Revenue in Rare Biomarkers Specimen Collection And Stabilization Business (2019-2024)
11.3.5 Creatv MicroTech Recent Development
11.4 Veridex
11.4.1 Veridex Company Detail
11.4.2 Veridex Business Overview
11.4.3 Veridex Rare Biomarkers Specimen Collection And Stabilization Introduction
11.4.4 Veridex Revenue in Rare Biomarkers Specimen Collection And Stabilization Business (2019-2024)
11.4.5 Veridex Recent Development
11.5 Creative-Bioarray
11.5.1 Creative-Bioarray Company Detail
11.5.2 Creative-Bioarray Business Overview
11.5.3 Creative-Bioarray Rare Biomarkers Specimen Collection And Stabilization Introduction
11.5.4 Creative-Bioarray Revenue in Rare Biomarkers Specimen Collection And Stabilization Business (2019-2024)
11.5.5 Creative-Bioarray Recent Development
11.6 Genetix
11.6.1 Genetix Company Detail
11.6.2 Genetix Business Overview
11.6.3 Genetix Rare Biomarkers Specimen Collection And Stabilization Introduction
11.6.4 Genetix Revenue in Rare Biomarkers Specimen Collection And Stabilization Business (2019-2024)
11.6.5 Genetix Recent Development
11.7 STRECK, INC.
11.7.1 STRECK, INC. Company Detail
11.7.2 STRECK, INC. Business Overview
11.7.3 STRECK, INC. Rare Biomarkers Specimen Collection And Stabilization Introduction
11.7.4 STRECK, INC. Revenue in Rare Biomarkers Specimen Collection And Stabilization Business (2019-2024)
11.7.5 STRECK, INC. Recent Development
11.8 Roche
11.8.1 Roche Company Detail
11.8.2 Roche Business Overview
11.8.3 Roche Rare Biomarkers Specimen Collection And Stabilization Introduction
11.8.4 Roche Revenue in Rare Biomarkers Specimen Collection And Stabilization Business (2019-2024)
11.8.5 Roche Recent Development
11.9 Amgen
11.9.1 Amgen Company Detail
11.9.2 Amgen Business Overview
11.9.3 Amgen Rare Biomarkers Specimen Collection And Stabilization Introduction
11.9.4 Amgen Revenue in Rare Biomarkers Specimen Collection And Stabilization Business (2019-2024)
11.9.5 Amgen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock